BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 33363540)

  • 1. Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success.
    Silvis MJM; Kaffka Genaamd Dengler SE; Odille CA; Mishra M; van der Kaaij NP; Doevendans PA; Sluijter JPG; de Kleijn DPV; de Jager SCA; Bosch L; van Hout GPJ
    Front Immunol; 2020; 11():599511. PubMed ID: 33363540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
    Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
    Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity and cardiomyocytes in ischemic heart disease.
    Lin L; Knowlton AA
    Life Sci; 2014 Mar; 100(1):1-8. PubMed ID: 24486305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A
    Alter C; Ding Z; Flögel U; Scheller J; Schrader J
    Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H190-H200. PubMed ID: 31050560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.
    Du M; Yang W; Schmull S; Gu J; Xue S
    Int Immunopharmacol; 2020 Jan; 78():106055. PubMed ID: 31816575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Imaging of Post-infarction Inflammation in Ischemic Cardiac Diseases - New Radiotracers for Potential Clinical Applications.
    Krenning BJ; der Heiden KV; Duncker DJ; de Jong M; Bernsen MR
    Curr Radiopharm; 2021; 14(3):184-208. PubMed ID: 33045975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice.
    Pluijmert NJ; Bart CI; Bax WH; Quax PHA; Atsma DE
    Sci Rep; 2020 Oct; 10(1):16601. PubMed ID: 33024178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical bone-derived stem cell therapy reduces apoptosis after myocardial infarction.
    Hobby ARH; Sharp TE; Berretta RM; Borghetti G; Feldsott E; Mohsin S; Houser SR
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H820-H829. PubMed ID: 31441690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Contributions to Myocardial Ischemia/Reperfusion Injury.
    Schanze N; Bode C; Duerschmied D
    Front Immunol; 2019; 10():1260. PubMed ID: 31244834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets.
    Arslan F; de Kleijn DP; Timmers L; Doevendans PA; Pasterkamp G
    Curr Pharm Des; 2008; 14(12):1205-16. PubMed ID: 18473868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction.
    Hofmann U; Frantz S
    Circ Res; 2015 Jan; 116(2):354-67. PubMed ID: 25593279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury.
    Chen C; Feng Y; Zou L; Wang L; Chen HH; Cai JY; Xu JM; Sosnovik DE; Chao W
    J Am Heart Assoc; 2014 Jan; 3(1):e000683. PubMed ID: 24390148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
    Vinten-Johansen J
    Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The innate immune response in reperfused myocardium.
    Timmers L; Pasterkamp G; de Hoog VC; Arslan F; Appelman Y; de Kleijn DP
    Cardiovasc Res; 2012 May; 94(2):276-83. PubMed ID: 22266751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal dynamics of immune response following prolonged myocardial ischemia/reperfusion with and without cyclosporine A.
    Rusinkevich V; Huang Y; Chen ZY; Qiang W; Wang YG; Shi YF; Yang HT
    Acta Pharmacol Sin; 2019 Sep; 40(9):1168-1183. PubMed ID: 30858476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of programmed necrosis limits infarct size through altered mitochondrial and immune responses in the aged female rat heart.
    Garvin AM; Jackson MA; Korzick DH
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1434-H1442. PubMed ID: 29957016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion.
    Liehn EA; Kanzler I; Konschalla S; Kroh A; Simsekyilmaz S; Sönmez TT; Bucala R; Bernhagen J; Weber C
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2180-6. PubMed ID: 23868943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in lung ischemia/reperfusion injury: unraveling the role of innate immunity.
    Li Q; Nie H
    Inflamm Res; 2024 Mar; 73(3):393-405. PubMed ID: 38265687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory response in myocardial infarction.
    Frangogiannis NG; Smith CW; Entman ML
    Cardiovasc Res; 2002 Jan; 53(1):31-47. PubMed ID: 11744011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison.
    Hashmi S; Al-Salam S
    Int J Clin Exp Pathol; 2015; 8(8):8786-96. PubMed ID: 26464621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.